Table of Content

1 Porcine Circovirus Type 2 (PCV2) Vaccine Market Overview
1.1 Product Overview and Scope of Porcine Circovirus Type 2 (PCV2) Vaccine
1.2 Porcine Circovirus Type 2 (PCV2) Vaccine Segment by Type
1.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 WH Type
1.2.3 LG Type
1.2.4 SH Type
1.2.5 SD Type
1.2.6 ZJ C Type
1.2.7 Others
1.3 Porcine Circovirus Type 2 (PCV2) Vaccine Segment by Application
1.3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value by Application: (2024-2034)
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size Estimates and Forecasts
1.4.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue 2024-2034
1.4.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales 2024-2034
1.4.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Porcine Circovirus Type 2 (PCV2) Vaccine Market Competition by Manufacturers
2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Manufacturers (2024-2024)
2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Manufacturers (2024-2024)
2.4 Global Porcine Circovirus Type 2 (PCV2) Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Product Type & Application
2.7 Porcine Circovirus Type 2 (PCV2) Vaccine Market Competitive Situation and Trends
2.7.1 Porcine Circovirus Type 2 (PCV2) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Porcine Circovirus Type 2 (PCV2) Vaccine Players Market Share by Revenue
2.7.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Porcine Circovirus Type 2 (PCV2) Vaccine Retrospective Market Scenario by Region
3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region: 2024-2034
3.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region: 2024-2024
3.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region: 2024-2034
3.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region: 2024-2034
3.3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region: 2024-2024
3.3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region: 2024-2034
3.4 North America Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Country
3.4.1 North America Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2034)
3.4.3 North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Country
3.5.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2034)
3.5.3 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2034)
3.6.3 Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Country
3.7.1 Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2034)
3.7.3 Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2034)
3.8.3 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2024-2034)
4.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2024-2024)
4.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Type (2024-2034)
4.1.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2024-2034)
4.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Type (2024-2034)
4.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Type (2024-2024)
4.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Type (2024-2034)
4.2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Type (2024-2034)
4.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Type (2024-2034)
5 Segment by Application
5.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2024-2034)
5.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2024-2024)
5.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Application (2024-2034)
5.1.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2024-2034)
5.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Application (2024-2034)
5.2.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Application (2024-2024)
5.2.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Application (2024-2034)
5.2.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Application (2024-2034)
5.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Zoetis Animal Health
6.1.1 Zoetis Animal Health Corporation Information
6.1.2 Zoetis Animal Health Description and Business Overview
6.1.3 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.1.5 Zoetis Animal Health Recent Developments/Updates
6.2 Boehringer-Ingelheim
6.2.1 Boehringer-Ingelheim Corporation Information
6.2.2 Boehringer-Ingelheim Description and Business Overview
6.2.3 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.2.5 Boehringer-Ingelheim Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Corporation Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Corporation Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 MSD Animal Health
6.5.1 MSD Animal Health Corporation Information
6.5.2 MSD Animal Health Description and Business Overview
6.5.3 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.5.4 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.5.5 MSD Animal Health Recent Developments/Updates
6.6 SPAH
6.6.1 SPAH Corporation Information
6.6.2 SPAH Description and Business Overview
6.6.3 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.6.4 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.6.5 SPAH Recent Developments/Updates
6.7 Nanjing Tianbang Biological Technology
6.6.1 Nanjing Tianbang Biological Technology Corporation Information
6.6.2 Nanjing Tianbang Biological Technology Description and Business Overview
6.6.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.7.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
6.8 Sichuan Huapai Bio-pharmaceutical
6.8.1 Sichuan Huapai Bio-pharmaceutical Corporation Information
6.8.2 Sichuan Huapai Bio-pharmaceutical Description and Business Overview
6.8.3 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.8.5 Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
6.9 Guangdong Winsun Bio Pharmaceutical
6.9.1 Guangdong Winsun Bio Pharmaceutical Corporation Information
6.9.2 Guangdong Winsun Bio Pharmaceutical Description and Business Overview
6.9.3 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.9.5 Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
6.10 Wuhan Keqian Biology
6.10.1 Wuhan Keqian Biology Corporation Information
6.10.2 Wuhan Keqian Biology Description and Business Overview
6.10.3 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.10.5 Wuhan Keqian Biology Recent Developments/Updates
6.11 Shanghai Hile Bio-Technology
6.11.1 Shanghai Hile Bio-Technology Corporation Information
6.11.2 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Description and Business Overview
6.11.3 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
6.12 Harbin Pharmaceutical Group Bio-Vaccine
6.12.1 Harbin Pharmaceutical Group Bio-Vaccine Corporation Information
6.12.2 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Description and Business Overview
6.12.3 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
6.13 Ringpu
6.13.1 Ringpu Corporation Information
6.13.2 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Description and Business Overview
6.13.3 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.13.5 Ringpu Recent Developments/Updates
6.14 Shandong Huahong Bioengineering
6.14.1 Shandong Huahong Bioengineering Corporation Information
6.14.2 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Description and Business Overview
6.14.3 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.14.5 Shandong Huahong Bioengineering Recent Developments/Updates
6.15 Weike Biotechnology
6.15.1 Weike Biotechnology Corporation Information
6.15.2 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Description and Business Overview
6.15.3 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.15.5 Weike Biotechnology Recent Developments/Updates
6.16 Nanjing Tianbang Biological Technology
6.16.1 Nanjing Tianbang Biological Technology Corporation Information
6.16.2 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Description and Business Overview
6.16.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.16.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
6.17 China Animal Husbandry Industry
6.17.1 China Animal Husbandry Industry Corporation Information
6.17.2 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Description and Business Overview
6.17.3 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.17.4 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product Portfolio
6.17.5 China Animal Husbandry Industry Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Circovirus Type 2 (PCV2) Vaccine Industry Chain Analysis
7.2 Porcine Circovirus Type 2 (PCV2) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Circovirus Type 2 (PCV2) Vaccine Production Mode & Process
7.4 Porcine Circovirus Type 2 (PCV2) Vaccine Sales and Marketing
7.4.1 Porcine Circovirus Type 2 (PCV2) Vaccine Sales Channels
7.4.2 Porcine Circovirus Type 2 (PCV2) Vaccine Distributors
7.5 Porcine Circovirus Type 2 (PCV2) Vaccine Customers
8 Porcine Circovirus Type 2 (PCV2) Vaccine Market Dynamics
8.1 Porcine Circovirus Type 2 (PCV2) Vaccine Industry Trends
8.2 Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers
8.3 Porcine Circovirus Type 2 (PCV2) Vaccine Market Challenges
8.4 Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) of Key Manufacturers (2024-2024)
Table 5. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Porcine Circovirus Type 2 (PCV2) Vaccine Average Price (US$/Dose) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Porcine Circovirus Type 2 (PCV2) Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Porcine Circovirus Type 2 (PCV2) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Circovirus Type 2 (PCV2) Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2024-2024) & (K Doses)
Table 18. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Region (2024-2024)
Table 19. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2024-2034) & (K Doses)
Table 20. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Region (2024-2024)
Table 23. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2024) & (K Doses)
Table 27. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2034) & (K Doses)
Table 28. North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2024) & (K Doses)
Table 32. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2034) & (K Doses)
Table 33. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2024-2024) & (K Doses)
Table 37. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Region (2024-2034) & (K Doses)
Table 38. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2024) & (K Doses)
Table 42. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2034) & (K Doses)
Table 43. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2024) & (K Doses)
Table 47. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales by Country (2024-2034) & (K Doses)
Table 48. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) by Type (2024-2024)
Table 51. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) by Type (2024-2034)
Table 52. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2024-2024)
Table 53. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Type (2024-2024)
Table 57. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Type (2024-2024)
Table 59. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Type (2024-2034)
Table 60. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) by Application (2024-2024)
Table 61. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses) by Application (2024-2034)
Table 62. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2024-2024)
Table 63. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Application (2024-2024)
Table 67. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Application (2024-2024)
Table 69. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Application (2024-2034)
Table 70. Zoetis Animal Health Corporation Information
Table 71. Zoetis Animal Health Description and Business Overview
Table 72. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 73. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 74. Zoetis Animal Health Recent Developments/Updates
Table 75. Boehringer-Ingelheim Corporation Information
Table 76. Boehringer-Ingelheim Description and Business Overview
Table 77. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 78. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 79. Boehringer-Ingelheim Recent Developments/Updates
Table 80. Merck Animal Health Corporation Information
Table 81. Merck Animal Health Description and Business Overview
Table 82. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 83. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 84. Merck Animal Health Recent Developments/Updates
Table 85. Ceva Santé Animale Corporation Information
Table 86. Ceva Santé Animale Description and Business Overview
Table 87. Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 88. Ceva Santé Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 89. Ceva Santé Animale Recent Developments/Updates
Table 90. MSD Animal Health Corporation Information
Table 91. MSD Animal Health Description and Business Overview
Table 92. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 93. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 94. MSD Animal Health Recent Developments/Updates
Table 95. SPAH Corporation Information
Table 96. SPAH Description and Business Overview
Table 97. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 98. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 99. SPAH Recent Developments/Updates
Table 100. Nanjing Tianbang Biological Technology Corporation Information
Table 101. Nanjing Tianbang Biological Technology Description and Business Overview
Table 102. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 103. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 104. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 105. Sichuan Huapai Bio-pharmaceutical Corporation Information
Table 106. Sichuan Huapai Bio-pharmaceutical Description and Business Overview
Table 107. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 108. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 109. Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
Table 110. Guangdong Winsun Bio Pharmaceutical Corporation Information
Table 111. Guangdong Winsun Bio Pharmaceutical Description and Business Overview
Table 112. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 113. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 114. Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
Table 115. Wuhan Keqian Biology Corporation Information
Table 116. Wuhan Keqian Biology Description and Business Overview
Table 117. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 118. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Shanghai Hile Bio-Technology Corporation Information
Table 121. Shanghai Hile Bio-Technology Description and Business Overview
Table 122. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 123. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 124. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 125. Harbin Pharmaceutical Group Bio-Vaccine Corporation Information
Table 126. Harbin Pharmaceutical Group Bio-Vaccine Description and Business Overview
Table 127. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 128. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 129. Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
Table 130. Ringpu Corporation Information
Table 131. Ringpu Description and Business Overview
Table 132. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 133. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 134. Ringpu Recent Developments/Updates
Table 135. Shandong Huahong Bioengineering Corporation Information
Table 136. Shandong Huahong Bioengineering Description and Business Overview
Table 137. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 138. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 139. Shandong Huahong Bioengineering Recent Developments/Updates
Table 140. Weike Biotechnology Corporation Information
Table 141. Weike Biotechnology Description and Business Overview
Table 142. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 143. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 144. Weike Biotechnology Recent Developments/Updates
Table 145. Nanjing Tianbang Biological Technology Corporation Information
Table 146. Nanjing Tianbang Biological Technology Description and Business Overview
Table 147. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 148. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 149. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 150. China Animal Husbandry Industry Corporation Information
Table 151. China Animal Husbandry Industry Description and Business Overview
Table 152. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 153. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product
Table 154. China Animal Husbandry Industry Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Porcine Circovirus Type 2 (PCV2) Vaccine Distributors List
Table 158. Porcine Circovirus Type 2 (PCV2) Vaccine Customers List
Table 159. Porcine Circovirus Type 2 (PCV2) Vaccine Market Trends
Table 160. Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers
Table 161. Porcine Circovirus Type 2 (PCV2) Vaccine Market Challenges
Table 162. Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Porcine Circovirus Type 2 (PCV2) Vaccine
Figure 2. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Share by Type in 2022 & 2034
Figure 4. WH Type Product Picture
Figure 5. LG Type Product Picture
Figure 6. SH Type Product Picture
Figure 7. SD Type Product Picture
Figure 8. ZJ C Type Product Picture
Figure 9. Others Product Picture
Figure 10. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Share by Application in 2022 & 2034
Figure 12. Piglets
Figure 13. Adults Pigs
Figure 14. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size (2024-2034) & (US$ Million)
Figure 16. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales (2024-2034) & (K Doses)
Figure 17. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price (US$/Dose) & (2024-2034)
Figure 18. Porcine Circovirus Type 2 (PCV2) Vaccine Report Years Considered
Figure 19. Porcine Circovirus Type 2 (PCV2) Vaccine Sales Share by Manufacturers in 2022
Figure 20. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Porcine Circovirus Type 2 (PCV2) Vaccine Players: Market Share by Revenue in 2022
Figure 22. Porcine Circovirus Type 2 (PCV2) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2024-2034)
Figure 25. North America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2024-2034)
Figure 26. United States Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2024-2034)
Figure 29. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2024-2034)
Figure 30. Germany Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Region (2024-2034)
Figure 37. China Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. China Taiwan Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2024-2034)
Figure 45. Latin America Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2024-2034)
Figure 46. Mexico Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Brazil Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Argentina Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Market Share by Country (2024-2034)
Figure 50. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Market Share by Country (2024-2034)
Figure 51. Turkey Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. UAE Porcine Circovirus Type 2 (PCV2) Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Porcine Circovirus Type 2 (PCV2) Vaccine by Type (2024-2034)
Figure 55. Global Revenue Market Share of Porcine Circovirus Type 2 (PCV2) Vaccine by Type (2024-2034)
Figure 56. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Type (2024-2034)
Figure 57. Global Sales Market Share of Porcine Circovirus Type 2 (PCV2) Vaccine by Application (2024-2034)
Figure 58. Global Revenue Market Share of Porcine Circovirus Type 2 (PCV2) Vaccine by Application (2024-2034)
Figure 59. Global Porcine Circovirus Type 2 (PCV2) Vaccine Price (US$/Dose) by Application (2024-2034)
Figure 60. Porcine Circovirus Type 2 (PCV2) Vaccine Value Chain
Figure 61. Porcine Circovirus Type 2 (PCV2) Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed